Chief Financial Officer · Cabaletta Bio, Inc. (CABA)

Anup Marda

FY2019 is the first fiscal year CompBrief holds for Anup Marda as a named executive officer of Cabaletta Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,528,634

Salary $303,189Stock awards $0Bonus $60,000

1st of 3 named executive officers at Cabaletta Bio by FY2019 total.

3 named officers on file for Cabaletta Bio, FY2019

Anup Marda’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cabaletta Bio’s whole pay program stands against its peers

  • Cabaletta Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CABA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2020 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Anup Marda’s full pay file as a PDF — free

More than this page: up to 10 years of Anup’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Anup Marda compensation by year

Cabaletta Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Cabaletta Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$303,189
Bonus$60,000
Stock awards$0
Option awards$980,437
Non-equity incentive$185,008
Pension and deferred compensation$0
All other$0
Total$1,528,634

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cabaletta Bio, Inc. DEF 14A filed April 23, 2020, accession 0001193125-20-115863, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cabaletta Bio, Inc. filed document, accession 0001193125-20-115863. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2020.

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option139,282—$4.23
Option66,463—$11.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Cabaletta Bio, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

18 Form 4 lines since the FY2019 proxy (filed April 23, 2020)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-03-02Grant or award derivative—225,000$0.00225,000
2025-05-19Grant or award derivative—66,463$0.0066,463
2025-05-19Grant or award derivative—100,000$0.00100,000
2025-05-19Grant or award derivative—135,000$0.00135,000
2025-05-19Grant or award derivative—130,000$0.00130,000
2025-05-19Grant or award derivative—139,282$0.00139,282
2025-05-19Disposition to the issuer derivative—24,711$0.000
2025-05-19Disposition to the issuer derivative—139,282$0.000

The 8 most recent of 18 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Cabaletta Bio’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Anup Marda · this pageChief Financial Officer$1,528,634
Steven NichtbergerPresident and Chief Executive Officer$1,499,000
Gwendolyn BinderExecutive Vice President, Science and Technology$1,221,083

The full Cabaletta Bio compensation record

free company brief

This page is one person within Cabaletta Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cabaletta Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Anup Marda's compensation dossier · One-time report. No refunds.